Advertisement

Topics

Global and Regional Molybdenum Powder Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

20:57 EST 1 Dec 2017 | BioPortfolio Reports

Summary

Molybdenum Mo is a silverywhite shiny metal, hard but at the same time softer and more flexible than tungsten. It has an excellent resistance to corrosion, good wear and resistance to abrasion, and superior thermal and electrical properties. It is an essential element when it comes to alloys, as it enhances hardenability and persistence of tempered and destroyed steels.

Market Segment as follows:

By Region

AsiaPacific

North America

Europe

South America

Middle East Africa

By Type

Mo%99.90%

Mo%99.95%

Others

By Application

Molybdenum Products

Alloys Products

Lubricant additive and Catalysts

Others

By Company

Molymet

H.C. Starck

Plansee

Exploiter

JDCMoly

Toshiba

Japan New Metal Co

Dongtai Fengfeng

China Molybdenum Co

The main contents of the report including:

Section 1:

Product definition, type and application, global and regional market overview;

Section 2:

Global and regional Market competition by company;

Section 3:

Global and regional sales revenue, volume and price by type;

Section 4:

Global and regional sales revenue, volume and price by application;

Section 5:

Regional export and import;

Section 6:

Company information, business overview, sales data and product specifications;

Section 7:

Industry chain and raw materials;

Section 8:

SWOT and Porter's Five Forces;

Section 9:

Conclusion.

Original Article: Global and Regional Molybdenum Powder Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global and Regional Molybdenum Powder Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...